BIOMAT Database Logo BIOMAT Database Logo

Linear accelerator stereotactic radiosurgery for vestibular schwannomas: a UK series. 2014

H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Hall-Edwards Radiotherapy Research Group, The Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK. Electronic address: paul.sanghera@uhb.nhs.uk.

OBJECTIVE To evaluate non-auditory toxicity and local control after linear accelerator stereotactic radiosurgery (SRS) for the treatment of vestibular schwannomas. METHODS The institutional policy was to use SRS for radiologically progressing vestibular schwannomas. Case notes and plans were retrospectively reviewed for all patients undergoing SRS for vestibular schwannomas between September 2002 and June 2012. All patients were surgically immobilised using a BrainLab stereotactic head frame. The treatment plan was generated using BrainLab software (BrainScan 5.03). The aim was to deliver 12 Gy to the surface of the target with no margin. Patients with a minimum of 12 months of follow-up were included for toxicity and local control assessment. Radiological progression was defined as growth on imaging beyond 2 years of follow-up. Overall local control was defined in line with other series as absence of surgical salvage. RESULTS Ninety-nine patients were identified. Two patients were lost to follow-up. After a median follow-up interval of 2.4 years, the actuarial radiological progression-free survival at 3 years was 100% and overall local control was also 100%. However, two patients progressed radiologically at 3.3 and 4.5 years, respectively. Twenty-one of 97 (22%) evaluable patients suffered trigeminal toxicity and this was persistent in 8/97 (8%). Two of 97 (2%) suffered long-term facial nerve toxicity (one with associated radiological progression causing hemi-facial spasm alone). One of 97 (1%) required intervention for obstructive hydrocephalus. No statistically significant dosimetric relationship could be shown to cause trigeminal or facial nerve toxicity. However, 7/8 patients with persistent trigeminal nerve toxicity had tumours in contact with the trigeminal nerve. CONCLUSIONS SRS delivering 12 Gy using a linear accelerator leads to high local control rates, but only prospective evaluation will fully establish short-term toxicity. In this study, persistent trigeminal toxicity occurred almost exclusively in patients whose tumour was in contact with the trigeminal nerve.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009464 Neuroma, Acoustic A benign SCHWANNOMA of the eighth cranial nerve (VESTIBULOCOCHLEAR NERVE), mostly arising from the vestibular branch (VESTIBULAR NERVE) during the fifth or sixth decade of life. Clinical manifestations include HEARING LOSS; HEADACHE; VERTIGO; TINNITUS; and FACIAL PAIN. Bilateral acoustic neuromas are associated with NEUROFIBROMATOSIS 2. (From Adams et al., Principles of Neurology, 6th ed, p673) Acoustic Neuroma,Melanocytic Vestibular Schwannoma,Schwannoma, Acoustic,Schwannoma, Vestibular,Acoustic Neuroma, Cerebellopontine Angle,Acoustic Tumor,Angle Tumor,Cerebellopontine Angle Acoustic Neuroma,Cerebellopontine Angle Tumor,Neurilemmoma, Acoustic,Neurilemoma, Acoustic,Neurinoma of the Acoustic Nerve,Neurinoma, Acoustic,Neuroma, Acoustic, Unilateral,Vestibular Schwannoma,Acoustic Neurilemmoma,Acoustic Neurilemmomas,Acoustic Neurilemoma,Acoustic Neurilemomas,Acoustic Neurinoma,Acoustic Neurinomas,Acoustic Neuromas,Acoustic Schwannoma,Acoustic Schwannomas,Acoustic Tumors,Angle Tumor, Cerebellopontine,Angle Tumors,Angle Tumors, Cerebellopontine,Cerebellopontine Angle Tumors,Melanocytic Vestibular Schwannomas,Neurilemmomas, Acoustic,Neurilemomas, Acoustic,Neurinomas, Acoustic,Neuromas, Acoustic,Schwannoma, Melanocytic Vestibular,Schwannomas, Acoustic,Schwannomas, Melanocytic Vestibular,Schwannomas, Vestibular,Tumor, Acoustic,Tumor, Angle,Tumor, Cerebellopontine Angle,Tumors, Acoustic,Tumors, Angle,Tumors, Cerebellopontine Angle,Vestibular Schwannoma, Melanocytic,Vestibular Schwannomas,Vestibular Schwannomas, Melanocytic
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D005154 Facial Nerve The 7th cranial nerve. The facial nerve has two parts, the larger motor root which may be called the facial nerve proper, and the smaller intermediate or sensory root. Together they provide efferent innervation to the muscles of facial expression and to the lacrimal and SALIVARY GLANDS, and convey afferent information for TASTE from the anterior two-thirds of the TONGUE and for TOUCH from the EXTERNAL EAR. Cranial Nerve VII,Marginal Mandibular Branch,Marginal Mandibular Nerve,Seventh Cranial Nerve,Nerve VII,Nerve of Wrisberg,Nervus Facialis,Nervus Intermedius,Nervus Intermedius of Wrisberg,Cranial Nerve VIIs,Cranial Nerve, Seventh,Facial Nerves,Mandibular Nerve, Marginal,Mandibular Nerves, Marginal,Marginal Mandibular Nerves,Nerve VIIs,Nerve, Facial,Nerve, Marginal Mandibular,Nerve, Seventh Cranial,Nerves, Marginal Mandibular,Nervus Faciali,Seventh Cranial Nerves,Wrisberg Nerve,Wrisberg Nervus Intermedius
D005260 Female Females
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Stereotactic radiosurgery of vestibular schwannomas with a linear accelerator.
January 1994, Acta neurochirurgica. Supplement,
H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Linear accelerator radiosurgery for vestibular schwannomas.
November 2006, Journal of neurosurgery,
H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Linear accelerator radiosurgery for vestibular schwannomas.
November 2006, Journal of neurosurgery,
H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Linear accelerator radiosurgery for vestibular schwannomas.
January 2008, Progress in neurological surgery,
H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Vestibular schwannomas: linear accelerator radiosurgery.
January 2001, Journal of neurosurgery,
H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Linear accelerator-based stereotactic radiosurgery for acoustic schwannomas.
March 1994, International journal of radiation oncology, biology, physics,
H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Management of vestibular schwannomas with linear accelerator-based stereotactic radiosurgery: a single center experience.
January 2013, Tumori,
H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
May 2008, Neurosurgery,
H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Stereotactic radiosurgery for vestibular schwannomas.
January 2018, Cancer management and research,
H Benghiat, and G Heyes, and P Nightingale, and A Hartley, and M Tiffany, and D Spooner, and J I Geh, and G Cruickshank, and R M Irving, and P Sanghera
Linear accelerator radiosurgery for treatment of vestibular schwannomas in neurofibromatosis 2.
July 2008, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Copied contents to your clipboard!